Functional Significance of CD133 in Pancreatic Cancer

Project: Research project

Project Details

Description

Pancreatic ductal adenocarcinoma (PDAC) is currently the fourth most frequent cause of cancer related deaths in United States due to propensity to metastasis, invasion and resistance to chemotherapy. All stage 5-year survival rate is
StatusActive
Effective start/end date4/1/14 → 3/30/20

Funding

  • National Institutes of Health: $318,513.00
  • National Institutes of Health: $315,400.00
  • National Institutes of Health: $318,513.00
  • National Institutes of Health: $318,513.00
  • National Institutes of Health: $315,400.00
View all
View less

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.